133 related articles for article (PubMed ID: 34224586)
1. Improvement of cardiac and systemic function in old mice by agonist of growth hormone-releasing hormone.
Xiang P; Jing W; Lin Y; Liu Q; Shen J; Hu X; Chen J; Cai R; Hare JM; Zhu W; Schally AV; Yu H
J Cell Physiol; 2021 Dec; 236(12):8197-8207. PubMed ID: 34224586
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Vascular Calcification by Growth Hormone-Releasing Hormone and Its Agonists.
Shen J; Zhang N; Lin YN; Xiang P; Liu XB; Shan PF; Hu XY; Zhu W; Tang YL; Webster KA; Cai R; Schally AV; Wang J; Yu H
Circ Res; 2018 May; 122(10):1395-1408. PubMed ID: 29618597
[TBL] [Abstract][Full Text] [Related]
3. Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH.
Schally AV; Wang H; He J; Cai R; Sha W; Popovics P; Perez R; Vidaurre I; Zhang X
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12028-12033. PubMed ID: 30373845
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
[TBL] [Abstract][Full Text] [Related]
5. Protection of neonatal rat cardiac myocytes against radiation-induced damage with agonists of growth hormone-releasing hormone.
Kiscsatári L; Varga Z; Schally AV; Gáspár R; Nagy CT; Giricz Z; Ferdinandy P; Fábián G; Kahán Z; Görbe A
Pharmacol Res; 2016 Sep; 111():859-866. PubMed ID: 27480202
[TBL] [Abstract][Full Text] [Related]
6. Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.
Florea V; Majid SS; Kanashiro-Takeuchi RM; Cai RZ; Block NL; Schally AV; Hare JM; Rodrigues CO
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17260-5. PubMed ID: 25404316
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure.
Gesmundo I; Miragoli M; Carullo P; Trovato L; Larcher V; Di Pasquale E; Brancaccio M; Mazzola M; Villanova T; Sorge M; Taliano M; Gallo MP; Alloatti G; Penna C; Hare JM; Ghigo E; Schally AV; Condorelli G; Granata R
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):12033-12038. PubMed ID: 29078377
[TBL] [Abstract][Full Text] [Related]
8. New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor.
Kanashiro-Takeuchi RM; Szalontay L; Schally AV; Takeuchi LM; Popovics P; Jaszberenyi M; Vidaurre I; Zarandi M; Cai RZ; Block NL; Hare JM; Rick FG
Oncotarget; 2015; 6(12):9728-39. PubMed ID: 25797248
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone-releasing hormone agonist attenuates vascular calcification in diabetic db/db mice.
Ren HL; Cai R; Xue R; Zhang Y; Xu Q; Zhang X; Cai R; Sha W; Schally AV; Zhou MS
Front Cardiovasc Med; 2023; 10():1102525. PubMed ID: 36742073
[TBL] [Abstract][Full Text] [Related]
10. Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI).
Kanashiro-Takeuchi RM; Takeuchi LM; Rick FG; Dulce R; Treuer AV; Florea V; Rodrigues CO; Paulino EC; Hatzistergos KE; Selem SM; Gonzalez DR; Block NL; Schally AV; Hare JM
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):559-63. PubMed ID: 22203988
[TBL] [Abstract][Full Text] [Related]
11. Actions and Potential Therapeutic Applications of Growth Hormone-Releasing Hormone Agonists.
Schally AV; Zhang X; Cai R; Hare JM; Granata R; Bartoli M
Endocrinology; 2019 Jul; 160(7):1600-1612. PubMed ID: 31070727
[TBL] [Abstract][Full Text] [Related]
12. Suppression of reactive oxygen species in endothelial cells by an antagonist of growth hormone-releasing hormone.
Akhter MS; Barabutis N
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22879. PubMed ID: 34369038
[TBL] [Abstract][Full Text] [Related]
13. GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways.
Penna C; Settanni F; Tullio F; Trovato L; Pagliaro P; Alloatti G; Ghigo E; Granata R
Endocrinology; 2013 Apr; 154(4):1624-35. PubMed ID: 23417421
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3',5'-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors.
Cunha SR; Mayo KE
Endocrinology; 2002 Dec; 143(12):4570-82. PubMed ID: 12446584
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction.
Kanashiro-Takeuchi RM; Tziomalos K; Takeuchi LM; Treuer AV; Lamirault G; Dulce R; Hurtado M; Song Y; Block NL; Rick F; Klukovits A; Hu Q; Varga JL; Schally AV; Hare JM
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2604-9. PubMed ID: 20133784
[TBL] [Abstract][Full Text] [Related]
16. Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction.
Dulce RA; Kanashiro-Takeuchi RM; Takeuchi LM; Salerno AG; Wanschel ACBA; Kulandavelu S; Balkan W; Zuttion MSSR; Cai R; Schally AV; Hare JM
Cardiovasc Res; 2023 Feb; 118(18):3586-3601. PubMed ID: 35704032
[TBL] [Abstract][Full Text] [Related]
17. Identification of two novel chicken GHRH receptor splice variants: implications for the roles of aspartate 56 in the receptor activation and direct ligand receptor interaction.
Wang CY; Wang Y; Kwok AH; Leung FC
J Endocrinol; 2007 Dec; 195(3):525-36. PubMed ID: 18000314
[TBL] [Abstract][Full Text] [Related]
18. Profound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells.
Ma Q; Xia X; Tao Q; Lu K; Shen J; Xu Q; Hu X; Tang Y; Block NL; Webster KA; Schally AV; Wang J; Yu H
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):663-672. PubMed ID: 26868211
[TBL] [Abstract][Full Text] [Related]
19. The growth hormone-releasing hormone receptor: desensitisation following short-term agonist exposure.
Hansen BS; Gerlach LO; Hansen A; Foged C; Andersen PH
Pharmacol Toxicol; 2001 Feb; 88(2):81-8. PubMed ID: 11169166
[TBL] [Abstract][Full Text] [Related]
20. Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.
Luque RM; Soares BS; Peng XD; Krishnan S; Cordoba-Chacon J; Frohman LA; Kineman RD
Endocrinology; 2009 Jul; 150(7):3177-85. PubMed ID: 19342460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
